Hepatology

Hepatitis B affects more than 296 million people worldwide, according to the World Health Organization (WHO). More than 1.5 million new infections occur each year, despite the availability of safe and effective vaccines.

Several presentations at the recent International Liver Congress™ (ILC), held in London, UK, from 22nd–26th of June 2022, addressed the role of the gut microbiome in chronic liver disease.

PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.

There is growing recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome that portends excessively high…

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and progressiveness include visceral obesity and Type 2 diabetes.

A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma.

Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.

I have always been curious, wanting to understand how and why everything works. My interest in biology began in secondary school in Ireland, where I had a very energetic teacher, Mr Whisker.